HomeALT • NASDAQ
add
Altimmune Inc
Previous close
$5.24
Year range
$2.90 - $9.95
Market cap
546.29M USD
Avg Volume
3.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Newsfile
1 hour ago
Canadian Gold Resources Announces Amended Non-brokered $2.9 Million LIFE Financing
0.00%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 5.00K | 0.00% |
Operating expense | 5.90M | 18.82% |
Net income | -19.01M | 16.77% |
Net profit margin | -380.28K | 16.77% |
Earnings per share | -0.21 | 34.38% |
EBITDA | -20.83M | 15.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 210.78M | 51.22% |
Total assets | 218.45M | 47.74% |
Total liabilities | 32.85M | 126.73% |
Total equity | 185.60M | — |
Shares outstanding | 104.25M | — |
Price to book | 2.70 | — |
Return on assets | -25.51% | — |
Return on capital | -27.54% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -19.01M | 16.77% |
Cash from operations | -11.90M | 56.13% |
Cash from investing | -149.32M | -12,553.79% |
Cash from financing | 39.35M | 14,692.86% |
Net change in cash | -121.87M | -375.07% |
Free cash flow | -6.80M | 64.14% |
About
Founded
1997
Headquarters
Website
Employees
59
